ARDELYX, INC. Earnings Per Share (Basic)
ARDELYX, INC. (ARDX) reported Earnings Per Share (Basic) of -$0.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- ARDELYX, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.07.
- ARDELYX, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.15.
- ARDELYX, INC. earnings per share, basic for the quarter ending 2025-09-30 was $0.00.
- ARDELYX, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.08.
- ARDELYX, INC. earnings per share, basic for fiscal 2025 was -$0.26.
- ARDELYX, INC. earnings per share, basic for fiscal 2024 was -$0.17.
- ARDELYX, INC. earnings per share, basic for fiscal 2023 was -$0.30.
- ARDELYX, INC. earnings per share, basic for fiscal 2022 was -$0.42.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.07 10-Q · filed 2026-08-06 | -$0.22 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$0.15 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | -$0.26 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-10-30 | -$0.25 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | -$0.08 10-Q · filed 2026-08-06 | -$0.25 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | -$0.17 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | -$0.17 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-10-30 | -$0.19 10-Q · filed 2025-10-30 | ||
| 2024-06-30 | -$0.07 10-Q · filed 2025-08-04 | -$0.18 10-Q · filed 2025-08-04 | ||
| 2024-03-31 | -$0.11 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | -$0.30 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $0.03 10-Q · filed 2024-10-31 | -$0.17 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | -$0.08 10-Q · filed 2024-08-01 | -$0.21 10-Q · filed 2024-08-01 | ||
| 2023-03-31 | -$0.13 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$0.42 10-K · filed 2025-02-20 | |||
| 2022-09-30 | -$0.14 10-Q · filed 2023-10-31 | -$0.53 10-Q · filed 2023-10-31 | ||
| 2022-06-30 | -$0.19 10-Q · filed 2023-08-02 | -$0.40 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | -$0.21 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | -$1.52 10-K · filed 2024-02-22 | |||
| 2021-09-30 | -$0.42 10-Q · filed 2022-11-03 | -$1.21 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | -$0.45 10-Q · filed 2022-08-04 | -$0.79 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$0.34 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$1.05 10-K · filed 2023-03-02 | |||
| 2020-09-30 | -$0.20 10-Q · filed 2021-11-12 | -$0.73 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$0.28 10-Q · filed 2021-08-13 | -$0.53 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$0.25 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | -$1.47 10-K · filed 2022-02-28 | |||
| 2017-12-31 | $0.21 10-K · filed 2019-03-06 | |||
| 2017-09-30 | -$0.44 10-K · filed 2019-03-06 | |||
| 2017-06-30 | -$0.54 10-K · filed 2019-03-06 | |||
| 2017-03-31 | -$0.59 10-K · filed 2019-03-06 | |||
| 2016-06-30 | -$0.83 10-Q · filed 2016-08-08 | -$1.53 10-Q · filed 2016-08-08 | ||
| 2015-12-31 | -$0.65 10-K · filed 2017-02-17 | |||
| 2015-09-30 | -$0.70 10-K · filed 2017-02-17 | -$0.58 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | $0.43 10-K · filed 2017-02-17 | $0.28 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | -$0.19 10-K · filed 2017-02-17 | |||
| 2014-12-31 | -$0.21 10-K · filed 2016-03-04 | |||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 | $0.06 derived: net income ÷ weighted average shares · filed 2015-11-12 | $0.00 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $0.20 10-K · filed 2016-03-04 | $0.00 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | -$2.44 10-K · filed 2016-03-04 | |||
| 2013-09-30 | -$0.81 10-Q · filed 2014-11-07 | -$1.62 derived: net income ÷ weighted average shares · filed 2014-11-07 | -$2.08 10-Q · filed 2014-11-07 | |
| 2013-06-30 | -$0.81 10-Q · filed 2014-08-08 | -$1.27 10-Q · filed 2014-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |